Business Context and Reporting Period
This Form 8-K Current Report for DaVita Inc. covers the date of April 25, 2005. The filing addresses a significant change in the company's executive leadership structure regarding the Chief Financial Officer position.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes rather than financial performance data.
Material Changes
- Departure of CFO: Denise K. Fletcher, Senior Vice President and Chief Financial Officer, has departed the company. Her employment agreement is terminated effective May 18, 2005.
- Appointment of Acting CFO: The Board of Directors approved the appointment of Thomas L. Kelly, Executive Vice President, as the acting Chief Financial Officer effective April 25, 2005.
Management Commentary and Background
Thomas L. Kelly, age 53, has served as Executive Vice President since June 2004. His background includes serving as President and CEO of Mercy Health Plans, Inc. (1994–2004) and holding various positions with KPMG LLP, including National Director – Healthcare (1991–1993). The filing confirms that Mr. Kelly's existing employment agreement terms remain unmodified and that he has no family relationships with other directors or officers.
Investor Verification Checklist
- Verify the effective date of Denise K. Fletcher's termination (May 18, 2005) and any associated severance details referenced in the April 21, 2005 Form 8-K.
- Confirm the duration of Thomas L. Kelly's tenure as acting CFO versus a permanent appointment.
- Review the referenced employment agreement (Exhibit 10.1) filed on August 5, 2004, for specific compensation terms applicable to the CFO role.